Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lang B et al. - In Guillain-Barre syndrome, newly described antibodies bind to complex gangliosides. General immunosuppression is still the main treatment, but novel treatments that reduce complement-mediated damage or inhibit the binding of pathogenic antibodies are beginning to look promising.


Today in Neurologic/Ophthalmic...keeping you current

Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09

The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09

Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Archives of Neurology, 11/19/09

Today in Rheumatic/Autoimmune...keeping you current

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address